Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Promoting Recovery After STroke With Amantadine

NCT05140148 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT05140148
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05140148 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Promoting Recovery After STroke With Amantadine
Lead sponsor
University of Pennsylvania
Phase
Phase 2
Overall status
Recruiting
Start date
February 1, 2022
Completion date
June 30, 2028
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

stroke hemorrhagic, stroke, ischemic